X

Xtant Medical Holdings
D

XTNT

0.60000
USD
-0.01
(-1.64%)
Market Closed
Volume
0
EPS
0
Div Yield
-
P/E
-5
Market Cap
83,405,074
Related Instruments
    ABT
    ABT
    1.785
    (1.34%)
    134.950 USD
    B
    BAX
    0.425
    (1.27%)
    33.840 USD
    BDX
    BDX
    -0.590
    (-0.26%)
    227.450 USD
    COO
    COO
    -0.180
    (-0.20%)
    88.490 USD
    EW
    EW
    -1.380
    (-1.85%)
    73.300 USD
    ISRG
    ISRG
    -15.37
    (-2.53%)
    591.50 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    SYK
    SYK
    -3.72
    (-0.96%)
    382.74 USD
    T
    TNDM
    -1.110
    (-3.45%)
    31.020 USD
    ZBH
    ZBH
    1.250
    (1.21%)
    104.890 USD
    More
News

Title: Xtant Medical Holdings

Sector: Healthcare
Industry: Medical Devices
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products includeOsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.